| 000 | 01467 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513092205.0 | ||
| 264 | 0 | _c19960809 | |
| 008 | 199608s 0 0 fre d | ||
| 022 | _a0013-7006 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDutoit, D | |
| 245 | 0 | 0 |
_a[Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses]. _h[electronic resource] |
| 260 |
_bL'Encephale _c |
||
| 300 |
_a417-24 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; English Abstract; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aErythrocytes _xenzymology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHaloperidol _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKetone Oxidoreductases _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 |
_aSchizophrenia, Paranoid _xdrug therapy |
| 650 | 0 | 4 | _aSchizophrenic Psychology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aThomas, P | |
| 700 | 1 | _aLeroux, J M | |
| 700 | 1 | _aVaiga, G | |
| 700 | 1 | _aPommery, J | |
| 700 | 1 | _aCottencin, O | |
| 700 | 1 | _aErb, F | |
| 700 | 1 | _aGoudemand, M | |
| 773 | 0 |
_tL'Encephale _gvol. 21 _gno. 6 _gp. 417-24 |
|
| 999 |
_c8672311 _d8672311 |
||